0 Bewertungen
ID

16428

Beschreibung

A Study of Pertuzumab in Participants With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02491892

Link

https://clinicaltrials.gov/show/NCT02491892

Stichworte

Versionen (2)
  1. 16.07.16 16.07.16 -
  2. 17.09.21 17.09.21 -
Hochgeladen am

16. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Breast Cancer NCT02491892

    Englisch

    Eligibility Breast Cancer NCT02491892

    1 Formulare  
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    females at least 18 years of age
    Beschreibung

    Gender | Age

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2]
    C0001779
    histologically-confirmed metastatic breast cancer with low her2 expression and at least one measurable lesion according to response evaluation criteria in solid tumors (recist)
    Beschreibung

    Carcinoma breast stage IV | HER-2 protein overexpression low | Measurable lesion

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0278488
    UMLS CUI [2,1]
    C3888504
    UMLS CUI [2,2]
    C0205251
    UMLS CUI [3]
    C1513041
    karnofsky performance status at least 80%
    Beschreibung

    Karnofsky Performance Status

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    disease progression on/after up to 2 different chemotherapy regimens, including an anthracycline-containing therapy
    Beschreibung

    Chemotherapy Quantity | Anthracycline Antibiotics | Disease Progression

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0392920
    UMLS CUI [1,2]
    C1265611
    UMLS CUI [2]
    C0003234
    UMLS CUI [3]
    C0242656
    left ventricular ejection fraction (lvef) at least 50%
    Beschreibung

    Left ventricular ejection fraction

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0428772
    adequate liver function
    Beschreibung

    Liver function

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0232741
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    pleural effusions, ascites, or bone lesions as the only manifestation(s) of cancer
    Beschreibung

    Malignant Neoplasm Manifestation of | Pleural effusion disorder | Ascites | Bone lesion

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0006826
    UMLS CUI [1,2]
    C1280464
    UMLS CUI [2]
    C0032227
    UMLS CUI [3]
    C0003962
    UMLS CUI [4]
    C0238792
    pulmonary or central nervous system (cns) metastases
    Beschreibung

    Secondary malignant neoplasm of lung | CNS metastases

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0153676
    UMLS CUI [2]
    C0686377
    chemotherapy, radiotherapy, or immunotherapy within 4 weeks; or hormone therapy within 2 weeks of day 1
    Beschreibung

    Chemotherapy | Therapeutic radiology procedure | Immunotherapy | Hormone Therapy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2]
    C1522449
    UMLS CUI [3]
    C0021083
    UMLS CUI [4]
    C0279025
    previous treatment with any drug that targets the her2 receptor family
    Beschreibung

    Pharmaceutical Preparation Targeting erbB-2 Receptor

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C1521840
    UMLS CUI [1,3]
    C0069515
    previous treatment with corticosteroids as cancer therapy
    Beschreibung

    cancer treatment | Adrenal Cortex Hormones

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0920425
    UMLS CUI [2]
    C0001617
    history of significant cardiac disease
    Beschreibung

    Heart Disease Significant

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0018799
    UMLS CUI [1,2]
    C0750502
    major surgery or trauma within 4 weeks of day 1
    Beschreibung

    major surgery | Major trauma

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0679637
    UMLS CUI [2]
    C0332677
    pregnant or lactating women
    Beschreibung

    Pregnancy | Breast Feeding

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Breast Cancer NCT02491892

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Gender | Age
    Item
    females at least 18 years of age
    boolean
    C0079399 (UMLS CUI [1])
    C0001779 (UMLS CUI [2])
    Carcinoma breast stage IV | HER-2 protein overexpression low | Measurable lesion
    Item
    histologically-confirmed metastatic breast cancer with low her2 expression and at least one measurable lesion according to response evaluation criteria in solid tumors (recist)
    boolean
    C0278488 (UMLS CUI [1])
    C3888504 (UMLS CUI [2,1])
    C0205251 (UMLS CUI [2,2])
    C1513041 (UMLS CUI [3])
    Karnofsky Performance Status
    Item
    karnofsky performance status at least 80%
    boolean
    C0206065 (UMLS CUI [1])
    Chemotherapy Quantity | Anthracycline Antibiotics | Disease Progression
    Item
    disease progression on/after up to 2 different chemotherapy regimens, including an anthracycline-containing therapy
    boolean
    C0392920 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    C0003234 (UMLS CUI [2])
    C0242656 (UMLS CUI [3])
    Left ventricular ejection fraction
    Item
    left ventricular ejection fraction (lvef) at least 50%
    boolean
    C0428772 (UMLS CUI [1])
    Liver function
    Item
    adequate liver function
    boolean
    C0232741 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Malignant Neoplasm Manifestation of | Pleural effusion disorder | Ascites | Bone lesion
    Item
    pleural effusions, ascites, or bone lesions as the only manifestation(s) of cancer
    boolean
    C0006826 (UMLS CUI [1,1])
    C1280464 (UMLS CUI [1,2])
    C0032227 (UMLS CUI [2])
    C0003962 (UMLS CUI [3])
    C0238792 (UMLS CUI [4])
    Secondary malignant neoplasm of lung | CNS metastases
    Item
    pulmonary or central nervous system (cns) metastases
    boolean
    C0153676 (UMLS CUI [1])
    C0686377 (UMLS CUI [2])
    Chemotherapy | Therapeutic radiology procedure | Immunotherapy | Hormone Therapy
    Item
    chemotherapy, radiotherapy, or immunotherapy within 4 weeks; or hormone therapy within 2 weeks of day 1
    boolean
    C0392920 (UMLS CUI [1])
    C1522449 (UMLS CUI [2])
    C0021083 (UMLS CUI [3])
    C0279025 (UMLS CUI [4])
    Pharmaceutical Preparation Targeting erbB-2 Receptor
    Item
    previous treatment with any drug that targets the her2 receptor family
    boolean
    C0013227 (UMLS CUI [1,1])
    C1521840 (UMLS CUI [1,2])
    C0069515 (UMLS CUI [1,3])
    cancer treatment | Adrenal Cortex Hormones
    Item
    previous treatment with corticosteroids as cancer therapy
    boolean
    C0920425 (UMLS CUI [1])
    C0001617 (UMLS CUI [2])
    Heart Disease Significant
    Item
    history of significant cardiac disease
    boolean
    C0018799 (UMLS CUI [1,1])
    C0750502 (UMLS CUI [1,2])
    major surgery | Major trauma
    Item
    major surgery or trauma within 4 weeks of day 1
    boolean
    C0679637 (UMLS CUI [1])
    C0332677 (UMLS CUI [2])
    Pregnancy | Breast Feeding
    Item
    pregnant or lactating women
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video